Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gut

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.49.3.443PMID 11511570PMCID PMC1728453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial.

  2020cited by this paper
• Effects of specific inhibition of cyclo‐oxygenase‐1 and cyclo‐oxygenase‐2 in the rat stomach with normal mucosa and after acid challenge

  2001cited by this paper
• NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.

  2000cited by this paper
• Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group.

  2000cited by this paper
• Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID‐enteropathy in the rat

  2000cited by this paper
• COX-2 selectivity and lack of gastrointestinal toxicity: true, true and unrelated.

  2000cited by this paper
• Is intestinal toxicity of nonsteroidal anti-inflammatory drugs accounted for by cyclooxygenase-1 inhibition?

  2000cited by this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa

  2000cited by this paper
• Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

  2000cited by this paper
• Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach

  1999cited by this paper
• No evidence of H pylori-NSAID interaction in ulcer formation Results of double-blind, placebo-controlled trials

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Anti-inflammatory Drugs

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.

  1999cited by this paper
• HGF triggers activation of the COX‐2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway

  1999cited by this paper
• Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

  1999cited by this paper
• COX 2-selective NSAIDs: biology, promises, and concerns.

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.

  1999cited by this paper
• Synergy between cyclo‐oxygenase‐2 induction and arachidonic acid supply in vivo: consequences for nonsteroidal antiinflammatory drug efficacy

  1999cited by this paper
• Update on aspirin in the treatment and prevention of cardiovascular disease.

  1999cited by this paper
• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cited by this paper
• Celecoxib approved as NSAID with some concessions on class warning.

  1999cited by this paper
• Omeprazole:Helicobacter pylori makes thee greater yet

  1999cited by this paper
• Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

  1999cited by this paper
• An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

  1999cited by this paper
• Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

  1999cited by this paper
• Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

  1999cited by this paper
• Expression of COX-1, COX-2, and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection.

  1999cited by this paper
• Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.

  1999cited by this paper
• Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.

  1999cited by this paper
• A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group.

  1999cited by this paper
• Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

  1999cited by this paper
• Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor.

  1998cited by this paper
• Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs.

  1998cited by this paper
• Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells

  1998cited by this paper
• The advent of highly selective inhibitors of cyclooxygenase--a review.

  1998cited by this paper
• Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa.

  1998cited by this paper
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats

  1998cited by this paper
• Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.

  1998cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa.

  1998cited by this paper
• Cyclooxygenase-2 as a therapeutic target

  1998cited by this paper
• Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2.

  1998cited by this paper
• Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2.

  1998cited by this paper
• Selective cyclo‐oxygenase‐2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach

  1998cited by this paper
• Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.

  1998cited by this paper
• Risk of Alzheimer's disease and duration of NSAID use

  1998cited by this paper
• Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats.

  1998cited by this paper
• Effects of Cyclooxygenase-2 Selective and Nitric Oxide-Releasing Nonsteroidal Antiinflammatory Drugs on Mucosal Ulcerogenic and Healing Responses of the Stomach

  1998cited by this paper
• Nitric oxide donating flurbiprofen (HCT 1026) causes less endoscopic damage in healthy volunteers than flurbiprofen

  1998cited by this paper
• Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats.

  1998cited by this paper
• Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats.

  1998cited by this paper
• Nitric oxide donor decreases neutrophil adhesion in both lung and peritoneum during peritonitis.

  1998cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.

  1998cited by this paper
• Helicobacter pylori, NSAIDs, and peptic ulcers.

  1998cited by this paper
• Helicobacter pylori Up-regulates Cyclooxygenase-2 mRNA Expression and Prostaglandin E2 Synthesis in MKN 28 Gastric Mucosal Cells in Vitro *

  1998cited by this paper
• Helicobacter pylori, NSAIDs, and peptic ulcers.

  1998cited by this paper
• Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide.

  1998cited by this paper
• Expression of the cyclooxygenase-2 gene in gastric epithelium.

  1997cited by this paper
• NSAID-Induced Mucosal Injury: Analysis of Gastric Toxicity with New Generation NSAIDs: Ulcerogenicity Compared with Ulcer Healing

  1997cited by this paper
• Risk of Alzheimer's disease and duration of NSAID use

  1997cited by this paper
• NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects

  1997cited by this paper
• Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage.

  1997cited by this paper
• Aspirin causes rapid up‐regulation of cyclo‐oxygenase‐2 expression in the stomach of rats

  1997cited by this paper
• Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.

  1997cited by this paper
• Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells.

  1997cited by this paper
• Cytoprotection and healing: Two unequal brethren

  1997cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• Helicobacter pylori infection and chronic gastric acid hyposecretion.

  1997cited by this paper
• Noncardiac chest pain: from nutcrackers to nociceptors.

  1997cited by this paper
• INDOMETHACIN DAMAGE TO RAT GASTRIC MUCOSA IS MARKEDLY DEPENDENT ON LUMINAL pH

  1996cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.

  1996cited by this paper
• Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

  1996cited by this paper
• Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

  1996cited by this paper
• Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Therapeutics and inflammatory bowel disease: a guide to the interpretation of randomized controlled trials.

  1996cited by this paper
• [Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse effects distal to the duodenum].

  1996cited by this paper
• A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity.

  1996cited by this paper
• Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

  1995cited by this paper
• A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats.

  1995cited by this paper
• Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.

  1995cited by this paper
• Review article: new insights into prostaglandins and mucosal defence.

  1995cited by this paper
• Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury

  1995cited by this paper
• Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase.

  1995cited by this paper
• The hydrophobic barrier properties of gastrointestinal mucus.

  1995cited by this paper
• Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

  1995cited by this paper
• Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

  1995cited by this paper
• Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach

  1995cited by this paper

• A novel triazole derivative ameliorates ethanol-induced gastric ulcer via a NOS2-centered inhibition of the AGE-RAGE pathway.

  2026cites this paper
• Exploring gastroprotective effect and mechanisms of epigallocatechin gallate‐impregnated black garlic in acidic ethanol‐induced gastric ulcer model mice

  2025cites this paper
• Alkylglycerol monooxygenase represses prostanoid biosynthesis in a sex-dependent manner

  2025cites this paper
• Exploring herbal synergies in the management of rheumatoid arthritis: a multifaceted approach to inflammation and joint health

  2025cites this paper
• Yeokwisan: Standardised Herbal Formula Enhancing Gastric Mucosal Protection Against Gastric Ulcers in Mice, a Preclinical Study

  2025cites this paper
• An Integrative Omics and Network Pharmacology Approach to Evaluate the Antiulcer Activity of Bombax ceiba L. Gum in Rats

  2025cites this paper
• The potential effects of cranberry extract on indomethacin-induced gastric ulcer in rats

  2025cites this paper
• COX‐2 Inhibitor Prediction With KNIME: A Codeless Automated Machine Learning‐Based Virtual Screening Workflow

  2025cites this paper
• Gastroprotective and Antioxidant Effects of Ferula Plant Extract Against Indomethacin Induced Gastric Ulcer in Rats

  2025cites this paper
• Ellagic acid protects against gastric ulcer in male rats by antioxidant and anti-inflammatory mechanisms: modulation of NF-κβ/COX-2 and Nrf2/HO-1 pathways

  2025cites this paper
• Investigation of the protective effects of ethanolic extract of ferula orientalis on lung tissue in sepsis model rat

  2025cites this paper
• Neuropeptide W facilitates chronic gastric ulcer healing by the regulation of cyclooxygenase and NF-κB signaling pathways

  2024cites this paper
• Argel's stemmoside C as a novel natural remedy for mice with alcohol-induced gastric ulcer based on its molecular mechanistic pathways.

  2024cites this paper
• Molecular docking, characterization, ADME/toxicity prediction, and anti-ulcer activity of new quercetin derivatives on indomethacin-induced gastric ulcer in mice.

  2024cites this paper
• Tamarix aphylla derived metabolites ameliorate indomethacin-induced gastric ulcers in rats by modulating the MAPK signaling pathway, alleviating oxidative stress and inflammation: In vivo study supported by pharmacological network analysis

  2024cites this paper
• The anti ulcerogenic effect of sildenafil and moringa on ulcers in rats.

  2024cites this paper
• Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review

  2024cites this paper
• Design, classification, and adverse effects of NSAIDs: A review on recent advancements.

  2024cites this paper
• Canine ovarian epithelial tumours: histopathological and immunohistochemical evaluation with proposed histopathological classification system.

  2024cites this paper
• Comparative GC Analysis of Valencia orange Ripe and Unripe Peel Essential Oils, Nano-formulation, Anti-Helicobacter Pylori and Anti-inflammatoryEvaluation: in vitro and in silico

  2023cites this paper
• Roles of endothelial prostaglandin I2 in maintaining synchronous spontaneous Ca2+ transients in rectal capillary pericytes

  2023cites this paper
• Effect of phylloquinone on indomethacin‐induced gastric ulceration in rats: Role of SIRT‐1

  2023cites this paper
• Changes in Protease-Activated Receptor and Trypsin-1 Expression Are Involved in the Therapeutic Effect of Mg2+ Supplementation in Type 2 Diabetes-Induced Gastric Injury in Male Adult Rats

  2023cites this paper
• Promising effect of Geranium robertianum L. leaves and Aloe vera gel powder on Aspirin®-induced gastric ulcers in Wistar rats: anxiolytic behavioural effect, antioxidant activity, and protective pathways

  2023cites this paper
• Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review

  2023cites this paper
• Acacetin Ameliorates Acetylsalicylic Acid-Induced Gastric Ulcer in Rats by Interfering with Oxidative Stress, Inflammation, and Apoptosis

  2023cites this paper
• Protective Effect of the Phycobiliproteins from Arthrospira maxima on Indomethacin-Induced Gastric Ulcer in a Rat Model

  2023cites this paper
• Gastrointestinal bleeding in athletes

  2023cites this paper
• Piceatannol Affects Gastric Ulcers Induced by Indomethacin: Association of Antioxidant, Anti-Inflammatory, and Angiogenesis Mechanisms in Rats

  2022cites this paper
• Aktivitas Antiulseratif Berbagai Tanaman Herbal dan Prospek Masa Depan Sebagai Tanaman Budidaya

  2022cites this paper
• Antioxidant Properties, Phytoactive Compounds and Potential Protective Action of Salvia officinalis Flowers Against Combined Gastro-Intestinal Ulcer and Diarrhea Experimentally Induced in Rat

  2022cites this paper
• Evaluation of the therapeutic role of allopurinol on bisphenol S gastric and renal toxicity in adult male albino rats: An in vivo study

  2022cites this paper
• Digestion Resistance of Soybean 7S Protein and Its Implications for Reinforcing the Gastric Mucus Barrier.

  2022cites this paper
• Naproxen sodium nanoparticles are less toxic and gastroprotective agents than the conventional NSAID drug naproxen sodium in Balb/c mice.

  2022cites this paper
• Design, Synthesis, in Vitro and in Silico Studies of Benzimidazole‐Linked Oxadiazole Derivatives as Anti‐inflammatory Agents

  2022cites this paper
• Evaluation of ethanol extracts from three species of Artocarpus as natural gastroprotective agents: in vivo and histopathological studies

  2022cites this paper
• Protective Effect of Pomegranate Peels Extracts Against Stomach Peptic-Ulcer Induced By Brexin In Albino Rats

  2021cites this paper
• Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model

  2021cites this paper
• RETRACTED ARTICLE: Antiulcer activity of ethanolic leaf extract of Capparis zeylanica against chemically induced ulcers

  2021cites this paper
• Propolis and Its Gastroprotective Effects on NSAID-Induced Gastric Ulcer Disease: A Systematic Review

  2021influential citation
• Comparative Study of the Efficacy of Prebiotics and Probiotics as Dietary Supplements in Rats with Gastric Ulcer

  2021cites this paper
• Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation

  2020cites this paper
• Role of bone marrow derived-mesenchymal stem cells against gastric ulceration: Histological, immunohistochemical and ultrastructural study

  2020cites this paper
• Carvedilol safeguards against aspirin-induced gastric damage in rats

  2020cites this paper
• Synthesis, gastroprotective and acute toxicity of bio-isosteric derivative of diclofenac

  2020cites this paper
• Rosmarinic Acid Enriched Fraction from Perilla frutescens Leaves Strongly Protects Indomethacin-Induced Gastric Ulcer in Rats

  2019cites this paper
• The prophylactic efficacy of Cardamom (Elettaria cardamomum) extract against aspirin-induced gastric ulcer in a rat model

  2019cites this paper
• Drugging cancer metabolism: Expectations vs. reality.

  2019cites this paper
• Comparative Histological and immunohistochemical study on the effect of curcumin and wild honey versus omeprazole on a rat model of gastric ulcer

  2019cites this paper
• Investigation into the Possible Risk Effects Associated with Drug and Alcohol-induced Gastrointestinal Ulcer in Wistar Albino Rats

  2019cites this paper
• Sıçanlarda İndometazin İle İndüklenen Mide Ülseri Üzerine Krom Pikolinatın Koruyucu Etkileri

  2019cites this paper
• Antiulcerogenic activity of the ethanolic extract of Licania macrophylla Benth

  2019cites this paper
• Altered cytokine expression in Helicobacter pylori infected patients with bleeding duodenal ulcer

  2019cites this paper
• The relatively selective cyclooxygenase‐2 inhibitor nimesulide: What's going on?

  2019cites this paper
• Ethanol-induced gastric ulcer in rats and intervention of tert-butylhydroquinone: Involvement of Nrf2/HO-1 signalling pathway

  2019influential citation
• Pain and its management in Flying-foxes and microbats

  2018cites this paper
• Role of COX-2 Promoter Methylation and Helicobacter pylori Infection in Impaired Gastric Ulcer Healing

  2018cites this paper
• Artesunate affords protection against aspirin-induced gastric injury by targeting oxidative stress and proinflammatory signaling

  2018cites this paper
• Inhibition of Intestinal Epithelial Wound Healing through Protease-Activated Receptor-2 Activation in Caco2 Cells

  2018cites this paper
• Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability.

  2018cites this paper
• Increased susceptibility of aging gastric mucosa to injury and delayed healing: Clinical implications

  2018cites this paper
• Secretome from hypoxia-conditioned adipose-derived mesenchymal stem cells promotes the healing of gastric mucosal injury in a rodent model.

  2018cites this paper
• Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits

  2018cites this paper
• Antioxidant and gastroprotective actions of butanol fraction of Zingiber officinale against diclofenac sodium‐induced gastric damage in rats

  2018cites this paper
• In Vitro, In Silico Elucidation of Antiurease Activity, Kinetic Mechanism and COX‐2 Inhibitory Efficacy of Coagulansin A of Withania coagulans

  2018cites this paper
• The expression of COX-2 and iNOS in ethanol and aspirin induced gastric ulcer rat models

  2018cites this paper
• Anti-ulcer effect of Gallarhois extract with anti-oxidant activity in an ICR model of ethanol/hydrochloride acid-induced gastric injury

  2018cites this paper
• Gastroprotective and Antiulcer Effects of Celastrus paniculatus Seed Oil Against Several Gastric Ulcer Models in Rats

  2018cites this paper
• Roles of prostaglandin E and EP receptors in mucosal protection and ulcerhealing in the gastrointestinal tract

  2017cites this paper
• Natural Products with Antiplatelet Action.

  2017cites this paper
• New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.

  2017cites this paper
• COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis

  2017cites this paper
• The Role of Protease-Activated Receptor-2 During Wound Healing in Intestinal Epithelial Cells

  2017cites this paper
• Efeito gastroprotetor e imunomodulador de Mimosa tenuiflora (Willd.) Poir (Fabaceae)

  2017cites this paper
• UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters

  2017cites this paper
• Anti-nociceptive Activity of Ethnomedicinally Important Analgesic Plant Isodon rugosus Wall. ex Benth: Mechanistic Study and Identifications of Bioactive Compounds

  2016cites this paper
• Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms.

  2016cites this paper
• Divergent Effects of Nigella Sativa Linn and Omebrazole on the Healing Of Gastric Ulcer in Adult Female Albino Rats

  2016influential citation
• Mitigating effect of Avicenna marina on indomethacin induced gastric ulcer in male albino rats

  2016cites this paper
• Complicaciones gástricas de tratamientos farmacológicos

  2016cites this paper
• NSAID-Induced Gastropathy and H. pylori Infection

  2016cites this paper
• Secondary metabolites for antiulcer activity

  2016cites this paper
• Cytosolic phospholipase A2α has a crucial role in the pathogenesis of DSS‐induced colitis in mice

  2016cites this paper
• Experimental study on gastroprotective efficacy and mechanisms of luteolin-7-O-glucoside isolated from Ophiorrhiza mungos Linn. in different experimental models

  2016cites this paper
• Centella asiatica Leaf Extract Protects Against Indomethacin-Induced Gastric Mucosal Injury in Rats

  2016cites this paper
• The role of PGE2 in intestinal inflammation and tumorigenesis.

  2015cites this paper
• EFFECT OF n-BUTANOL FRACTION OF NIGELLA SATIVA ( L . ) SEED EXTRACT ON NSAID-INDUCED GASTRIC MUCOSAL INJURY ON GASTRIC HORMONES IN RATS

  2015cites this paper
• Peptic Ulcer aetiology; role of H, K-ATPase enzyme and biochemical mediators in a reserpine induced ulcer model

  2015cites this paper
• O cetoprofeno como oportunidade terapêutica no estresse oxidativo: uma revisão

  2015influential citation
• In Vivo Gastroprotective Effect along with Pharmacokinetics, Tissue Distribution and Metabolism of Isoliquiritigenin in Mice

  2015cites this paper
• Ethanolic leaf extract of Langenaria breviflora (bitter gourd) inhibits gastric onslaught in indomethacininduced ulcerated rats

  2015cites this paper
• Role of dietary polyphenols in the management of peptic ulcer.

  2015cites this paper
• Gastroprotective effect of andrographolide sodium bisulfite against indomethacin-induced gastric ulceration in rats.

  2015cites this paper
• Protective activity of crocin against indomethacin-induced gastric lesions in rats

  2015cites this paper
• Model‐based prediction of the acute and long‐term safety profile of naproxen in rats

  2015cites this paper
• Nonsteroidal Anti-Inflammatory Drugs and Corticosteroids

  2014cites this paper
• Natural Product Research: Formerly Natural Product Letters

  2014cites this paper
• The Effect of Celecoxib Administration on the Healing and Neovascularization of Colonic Anastomosis in Rats

  2014cites this paper
• Antiulcer activity of Muntingia calabura leaves involves the modulation of endogenous nitric oxide and nonprotein sulfhydryl compounds

  2014cites this paper
• The effect of aspirin administration length on KI-67 expression protein and oral epithelial mucosal thickness in male Wistar mice

  2014cites this paper